An initial evaluation of the use of the Cambridge algorithm in toddlers demonstrated the feasibility of hybrid closed-loop insulin delivery in young children with diabetes (14), whereby parents reported reduced diabetes management burden and improved sleep quality (15). This evidence concerns the gene INS and diabetes mellitus.